185 related articles for article (PubMed ID: 6304187)
1. Identification of circulating maternal T and B lymphocytes in uncomplicated severe combined immunodeficiency by HLA typing of subpopulations of T cells separated by the fluorescence-activated cell sorter and of Epstein Barr virus-derived B cell lines.
Geha RS; Reinherz E
J Immunol; 1983 Jun; 130(6):2493-5. PubMed ID: 6304187
[TBL] [Abstract][Full Text] [Related]
2. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
Roberts JL; Volkman DJ; Buckley RH
J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604
[TBL] [Abstract][Full Text] [Related]
3. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.
Palmer K; Green TD; Roberts JL; Sajaroff E; Cooney M; Parrott R; Chen DF; Reinsmoen NL; Buckley RH
J Allergy Clin Immunol; 2007 Aug; 120(2):423-8. PubMed ID: 17481714
[TBL] [Abstract][Full Text] [Related]
4. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
Le Deist F; Raffoux C; Griscelli C; Fischer A
J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121
[TBL] [Abstract][Full Text] [Related]
5. Phenotype and function of engrafted maternal T cells in patients with severe combined immunodeficiency.
Thompson LF; O'Connor RD; Bastian JF
J Immunol; 1984 Nov; 133(5):2513-7. PubMed ID: 6090535
[TBL] [Abstract][Full Text] [Related]
6. Severe combined immunodeficiency in man with an absence of immunoglobulin gene rearrangements but normal T cell receptor assembly.
Thompson A; Hendriks RW; Kraakman ME; Koning F; Langlois-van den Bergh R; Vossen JM; Weemaes CM; Schuurman RK
Eur J Immunol; 1990 Sep; 20(9):2051-6. PubMed ID: 2170148
[TBL] [Abstract][Full Text] [Related]
7. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency.
Pollack MS; Kirkpatrick D; Kapoor N; Dupont B; O'Reilly RJ
N Engl J Med; 1982 Sep; 307(11):662-6. PubMed ID: 7050708
[No Abstract] [Full Text] [Related]
8. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.
Bacchetta R; Vandekerckhove BA; Touraine JL; Bigler M; Martino S; Gebuhrer L; de Vries JE; Spits H; Roncarolo MG
J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037
[TBL] [Abstract][Full Text] [Related]
9. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
Plotnicky H; Touraine JL
Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
[TBL] [Abstract][Full Text] [Related]
10. Human severe combined immunodeficiency disease: phenotypic and functional characteristics of peripheral B lymphocytes.
Gougeon ML; Drean G; Le Deist F; Dousseau M; Fevrier M; Diu A; Theze J; Griscelli C; Fischer A
J Immunol; 1990 Nov; 145(9):2873-9. PubMed ID: 2212666
[TBL] [Abstract][Full Text] [Related]
11. The use of T cell culture techniques to establish the presence of an intrauterine-derived maternal T cell graft in a patient with severe combined immunodeficiency (SCID).
Flomenberg N; Dupont B; O'Reilly RJ; Hayward A; Pollack MS
Transplantation; 1983 Dec; 36(6):733-5. PubMed ID: 6606881
[No Abstract] [Full Text] [Related]
12. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
[TBL] [Abstract][Full Text] [Related]
13. Provision of Epstein-Barr virus-transformed B-cell lines in a routine tissue typing laboratory: practicalities and applications.
Bass H; Walters R; Darke C
Eur J Immunogenet; 2004 Apr; 31(2):87-92. PubMed ID: 15086349
[TBL] [Abstract][Full Text] [Related]
14. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
[TBL] [Abstract][Full Text] [Related]
16. The evolution of MHC restrictions in antigen recognition by T cells in a haploidentical bone marrow transplant recipient.
Geha RS; Rosen FS
J Immunol; 1989 Jul; 143(1):84-8. PubMed ID: 2567317
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
Bohlen H; Manzke O; Titzer S; Lorenzen J; Kube D; Engert A; Abken H; Wolf J; Diehl V; Tesch H
Cancer Res; 1997 May; 57(9):1704-9. PubMed ID: 9135012
[TBL] [Abstract][Full Text] [Related]
19. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
Mori T; Koishi T; Fujii G; Ohsawa N
Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
[TBL] [Abstract][Full Text] [Related]
20. T- and B-lymphocytes in immunological disorders.
Yata J; Okumura K; Nakagawa T; Sumiya M
Allerg Immunol (Leipz); 1974-1975; 20-21(4):403-12. PubMed ID: 4377862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
